(2)) than the nine benign lesions (5 (4)).
Fibreoptic bronchoscopy is a well established and useful diagnostic tool for lung tumours. In peripheral lesions, defined as tumours invisible at bronchoscopy, biplanar or uniplanar fluoroscopy has been widely used to improve the diagnostic yield.'2 Several different procedures using fibreoptic bronchoscopy have had variable success. 3 Specimens taken from a site as close as possible to the lesion should give optimal results, but the diagnostic rate ofbrushing with fluoroscopy has remained low (30-78%). 24 5Repeated brush biopsy has been reported to achieve a higher diagnostic yield.6 Transthoracic fine needle aspiration (FNA) biopsy under fluoroscopy or computed tomographic (CT) scanning could provide a diagnostic rate of over 90% for malignant nodules.78 However, complications including pneumothorax and intrapulmonary bleeding occur in 25-36% and 5-10% of cases, respectively.7`10 In addition, fluoroscopy or CT scanning is not routinely available in many respiratory units. An approach which can give a high diagnostic yield without fluoroscopy, together with a low incidence of serious complications, is desirable. We propose a new method using repeated bronchial brushings via the fibreoptic bronchoscope with immediate cytological examination using Riu's stain,"1 a method modified from Wright's stain. The stain has the advantage of a long shelf life and short staining time (two minutes including fixation).
Methods

SUBJECTS
Thirty eight patients (23 men) aged 31-83 years who presented with pulmonary masses on their chest radiographs to the pulmonary service of Chang Gung Memorial Hospital, Taipei, Taiwan, between July 1990 and September 1993 were studied prospectively. The size of the lesion on the radiograph was determined as the largest diameter and was agreed upon by two chest physicians. Of the 38 patients, 15 (10) , left upper lobe (six), lingula (two), and left lower lobe (eight). The most common location for malignant lesions was the right upper lobe.
STUDY DESIGN
The probable location of the tumour was determined initially by conventional posteroanterior and lateral chest radiography or computed tomographic scanning. Flexible fibreoptic bronchoscopy (Olympus BF-P10) without fluoroscopic guidance was then performed transnasally using 2% xylocaine for local anaesthesia. Each patient had supplemental oxygen administered routinely by nasal cannula and was monitored for heart rate and rhythm. Midazolam (0 05-0 07 mg/kg intravenously) was occasionally used to reduce anxiety in patients receiving a prolonged bronchoscopy. At the appropriate predetermined segment several orifices of the subsegmental bronchi were visualised and the tip of the bronchoscope advanced as far as possible. Bronchial brushings were taken with a nylon brush (Olympus BC-1J) from the subsegmental bronchus considered likely to contain the lesion, advancing it as far as possible. The whole bronchoscope with the brush was then withdrawn and the specimen was spread immediately onto two glass slides which were separated thereafter. One slide was air dried and immediately stained with Riu's stain. The other was immersed in 95% alcohol and submitted for the standard Papanicolaou's stain. The specimen with Riu's stain was immediately evaluated by light microscopy. If the specimen was negative for malignancy the procedure was repeated on another subsegmental bronchus until all the suspected subsegmental bronchi had been assessed. When all bronchial brushings were negative with Riu's stain the pulmonary lesion was considered to be benign. If the Riu's stain specimen was positive, the lesion was considered to be malignant. The judgement was later confirmed by comparing the findings with those of the histological examination of any subsequent surgical biopsy specimens, the Papanicolaou stain brush cytological examination, or the clinical course. Specimens were interpreted by the cytopathologist without prior knowledge of the histological result. Histological specimens were stained with haematoxylin and eosin and also interpreted by independent pathologists without prior knowledge of the clinical course. of medicinal extra pure methylene blue, and 100 ml of absolute methanol. Eosin Y is dissolved in the methanol and the methylene blue is added. The solution is shaken, allowed to stand for 24 hours, and filtered before use. Some precipitation may sometimes reappear 2-3 days after the first filtering, in which case the solution is filtered again and kept in a clear glass bottle. It may be preserved for a long time if the bottle is tightly stoppered.
Solution B This consists of 0-7 g medicinal extra pure methylene blue, 0-6-0-7 g azure I, 6-25 g KH2PO4, 12-6 g Na2HP04 12H2O), and 500ml distilled water. The Na2HP04 12H2O and KH2PO4 are first dissolved in distilled water, while azure I is ground in a mortar and added gradually to the buffer solution. Azure I is dissolved maximally by this means. The solution is put into a flask and the methylene blue added, shaken vigorously, and filtered after 24 hours. It can be preserved for a long time. The staining effect increases with aging.
Staining method
Staining is carried out after the smeared specimen has dried in air. Two to three drops of solution A are put on the slide for 30 seconds, then two to three drops of solution B are added for 60 seconds and the slide is rinsed in running water. The total time for staining is only 90 seconds.
STATISTICAL ANALYSIS
The unpaired t test was used to compare the numbers of bronchial brushings required for benign or malignant lesions, and tumour size. Differences of location were compared by ANOVA, and the correlation between the number of bronchial brushings and the sensitivity for malignancy by linear regression. A p value of <0 05 was considered statistically significant.
Results
Using repeated bronchial brushings and immediate Riu's stain 25 patients were classified as having a malignant tumour and 13 were considered to be benign. When compared with the final diagnosis the overall diagnostic accuracy rate was 89%. The diagnostic sensitivity for malignancy in patients with a tumour >3 cm in diameter was 88%, which was better than that in patients with a tumour of < 3 cm (83%) (table 1). The overall diagnostic yield for tumours of (3 cm compared with those of >3cm in diameter was 87% and 91%, respectively. No false positive diagnosis of malignancy was made in patients with benign lesions. The false negative rate for malignancy was 14%. In the four lesions which were proved to be false negative two were (3 cm and two were >3 cm in diameter.
Of the 34 subjects who were accurately identified, a positive diagnosis of malignant disease was established with a mean (SD) of 3 (2) bronchial brushings, which was significantly less than the 5 (4) brushings required for those Overall diagnostic accuracy rate 87% for tumour size < 3 cm, 91% for tumour size >3 cm, and 89% for total. with benign lesions (p<005). There was no significant difference in the numbers of bronchial brushings required based on tumour size or anatomical location (table 2) . In diagnosing malignancy the sensitivity of the first brushing was only 21%, but increased progressively to 86% with an increasing number of samples (r=0-89, p<0 02). The same tendency was observed for both small ( < 3 cm, r=0-88, p<005) and large masses (>3 cm, r= 0 99, p<0 001) (table 3) .
There were no complications such as pneumothorax or massive haemoptysis. The time for each cytological examination after each brushing was less than five minutes. Patients could rest between brushings and most of the procedures were completed within one hour. Even for the patient who received 14 brushings the procedure took just one and a half hours. There were no serious arrhythmias and the procedure was well tolerated by our patients who all received supplemental oxygen during the bronchoscopy.
There were no false positive cytological results from the Riu's stain and 80% ofthe cell type diagnoses from the Riu's stain interpretations were consistent with the final histological diagnoses. The cytological diagnosis matched the histological diagnosis in all seven cases of squamous cell carcinoma, five of six cases 
